JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klide, A. M.
Right arrow Articles by Aviado, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klide, A. M.
Right arrow Articles by Aviado, D. M.
Journal of Pharmacology And Experimental Therapeutics, Vol. 158, Issue 1, 28-35, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics


MECHANISM FOR THE REDUCTION IN PULMONARY RESISTANCE INDUCED BY HALOTHANE

Alan M. Klide 1 and Domingo M. Aviado 1

1 Department of Pharmacology, School of Medicine, University of Pennsylvania, Phildelphia, Pennsylvania

The mechanism for the bronchodilator properties of halothane was investigated in the dog. In 18 dogs without premedication, administration of 0.5 to 3.0% halothane in oxygen caused a reduction in pulmonary resistance and increase in compliance. Increase of halothane arterial blood levels from 15 to 30 mg/100 ml caused a decrease in pulmonary resistance of 40%, a rise in compliance of 24% and a decrease of respiratory minute volume of 37%. Changes in pulmonary resistance could still be elicited after the following procedures: bilateral acute or chronic upper thoracic sympathectomy, bilateral adrenalectomy, intravenous administration of hexamethonium, reserpine, guanethidine or bretylium. The only drug which eliminated the response was compound MJ 1999 (dl-4-(2-isopropylamino-1-hydroxethyl)-methanesulfonanilide HCl), a beta adrenergic blocking agent. We conclude that halothane stimulates the beta receptors in the airway.

Submitted on March 20, 1967
Accepted on May 23, 1967







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.